Bremelanotide

Therapeutic

used to treat hypoactive sexual desire disorder in premenopausal women

Structural features

SMILES

CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CN=CN2)NC1=O)C(O)=O

Sequence

Ac-XDHfRWK

Molar mass

1025.182 g/mol

Constitutional members:

7

Natural amino acids

5

D-Amino acids

1

N-terminus

acetyl

C-terminus

COOH

Cyclic

yes

Members/cycle

6

Bond to form cycle

side chain-to-side chain (amide Lys-Asp)

Lipidation

no

Glycosylation

no

Route of administration

SC

Terminal half-life

2.7 hours

Protein binding

0.21

Absorption and Bioavailability

1

References